Scarica l'app Stockscreener
1.37
6.20%
0.08
Shattuck Labs Inc Borsa (STTK) Ultime notizie
Shattuck Labs reports positive preclinical SL-325 data By Investing.com - Investing.com Nigeria
Shattuck Labs reports positive preclinical SL-325 data - Investing.com
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at ... - The Bakersfield Californian
Breakthrough in IBD Treatment? Shattuck's Novel DR3 Blocker Achieves Perfect Safety Score - StockTitan
Shattuck Labs (STTK) Expected to Announce Earnings on Wednesday - Defense World
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times
GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025 - The Manila Times
Revolutionary IBD Drug Development: Shattuck Labs Unveils Critical DR3 Antibody Results at ECCO 2025 - StockTitan
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights - br.ADVFN.com
Anti-DR3 antibody demonstrates efficacy in the treatment of IBD - BioWorld Online
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress - The Manila Times
Skye Bioscience Announces Participation in February Conferences - The Manila Times
Shattuck Labs, Inc. to Present Novel Research on SL-325 at 2025 Crohn’s and Colitis Congress - Nasdaq
Pivotal IBD Drug Development: Shattuck Labs Reveals SL-325 Data at Major Crohn's Congress - StockTitan
JPMorgan Chase & Co. Grows Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Planet Image International Leads 3 US Penny Stocks To Consider - Simply Wall St
Cresco Labs (OTCMKTS:CRLBF) Trading 2.1% Higher – What’s Next? - Defense World
ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting - BioSpace
Can ALX Break The CD47 Curse? - News & Insights
AXA (EPA:CS) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Barclays PLC Has $189,000 Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Stabilus (OTCMKTS:SBLUY) Stock Price Up 10.9% – Still a Buy? - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Sold by Jane Street Group LLC - Defense World
Luna Innovations Incorporated (NASDAQ:LUNA) Shares Sold by Jane Street Group LLC - Defense World
Jane Street Group LLC Boosts Stock Holdings in System1, Inc. (NYSE:SST) - Defense World
Barclays PLC Buys 40,717 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Geode Capital Management LLC Raises Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Shattuck Labs highlights upcoming key milestones in 2025 - Yahoo Finance
Shattuck Labs gears up for DR3 antagonist trials in 2025 By Investing.com - Investing.com Australia
Shattuck Labs gears up for DR3 antagonist trials in 2025 - Investing.com
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - The Manila Times
Shattuck Labs Unveils 2025 Pipeline Roadmap: Key SL-325 Clinical Milestones, $90M Cash Position - StockTitan
State Street Corp Acquires 55,579 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Barfresh Food Group And 2 Other US Penny Stocks To Consider - Simply Wall St
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat
Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com
New VC fund from hedge fund luminary seeks to raise $100M, filing shows - The Business Journals
GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan
Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St
Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada
Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India
Citigroup Downgrades Shattuck Labs (STTK) - MSN
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):